Literature DB >> 19854170

Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase.

Barbro Ek-Rylander1, Göran Andersson.   

Abstract

Osteopontin (OPN) is a multifunctional protein implicated in cellular adhesion and migration. Phosphorylation has emerged as a post-translational modification important for certain biological activities of OPN. This study demonstrates that adhesion of isolated neonatal rat osteoclasts in vitro was augmented on bovine milk osteopontin (bmOPN) with post-translational modifications (PTMs) compared to human Escherichia-coli-derived recombinant OPN (hrOPN) without PTMs. The difference in adhesiveness between these OPN variants was more pronounced at low coating concentrations (</= 10 mug/ml). Both OPN forms adhered exclusively using a beta(3)-integrin. Partial (</=50%) dephosphorylation by tartrate-resistant acid phosphatase (TRAP) in vitro reduced osteoclast attachment to bmOPN to the same level as to hrOPN, demonstrating the importance of specific phosphorylations in OPN-dependent osteoclast adhesion. The involvement of PTMs of OPN in migration of primary rat and mouse osteoclasts was assessed on culture dishes coated with the different OPN forms and then overlaid with gold particles. Here, osteoclasts exhibited haptotactic migration on bmOPN but did not migrate on hrOPN. The presence of neutralizing antibodies to TRAP inhibited migration on bmOPN. Moreover, migration of osteoclasts isolated from TRAP-overexpressing transgenic mice was augmented on bmOPN, but not on hrOPN or type I collagen. These data collectively provide evidence in favor of a role for endogenous TRAP in regulating osteoclast migration on post-translationally modified OPN. In a tissue context, modulation of the phosphorylation level of OPN by extracellular phosphatases, e.g., TRAP, could regulate the extent of degradation such as depth and area at each bone resorption site by triggering osteoclast detachment and facilitate subsequent migration on the bone surface. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19854170     DOI: 10.1016/j.yexcr.2009.10.019

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  27 in total

1.  Pre- and post-translational regulation of osteopontin in cancer.

Authors:  Pieter H Anborgh; Jennifer C Mutrie; Alan B Tuck; Ann F Chambers
Journal:  J Cell Commun Signal       Date:  2011-04-26       Impact factor: 5.782

Review 2.  Regulation of lysosome biogenesis and functions in osteoclasts.

Authors:  Julie Lacombe; Gérard Karsenty; Mathieu Ferron
Journal:  Cell Cycle       Date:  2013-08-05       Impact factor: 4.534

3.  Osteopontin signals through calcium and nuclear factor of activated T cells (NFAT) in osteoclasts: a novel RGD-dependent pathway promoting cell survival.

Authors:  Natsuko Tanabe; Benjamin D Wheal; Jiyun Kwon; Hong H Chen; Ryan P P Shugg; Stephen M Sims; Harvey A Goldberg; S Jeffrey Dixon
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

Review 4.  The interplay between extracellular matrix remodelling and kinase signalling in cancer progression and metastasis.

Authors:  Joanna N Skhinas; Thomas R Cox
Journal:  Cell Adh Migr       Date:  2017-12-29       Impact factor: 3.405

5.  Phosphorylation of osteopontin has proapoptotic and proinflammatory effects on human knee osteoarthritis chondrocytes.

Authors:  Shu-Guang Gao; Yang Yu; Chao Zeng; Shi-Tao Lu; Jian Tian; Chao Cheng; Liang-Jun Li; Guang-Hua Lei
Journal:  Exp Ther Med       Date:  2016-10-05       Impact factor: 2.447

Review 6.  Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers.

Authors:  Thomas E Kruger; Andrew H Miller; Andrew K Godwin; Jinxi Wang
Journal:  Crit Rev Oncol Hematol       Date:  2013-09-07       Impact factor: 6.312

7.  Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis.

Authors:  Shamik Das; Rajeev S Samant; Lalita A Shevde
Journal:  J Biol Chem       Date:  2010-12-18       Impact factor: 5.157

8.  Differential expression of tartrate-resistant acid phosphatase isoforms 5a and 5b by tumor and stromal cells in human metastatic bone disease.

Authors:  Serhan Zenger; Wentao He; Barbro Ek-Rylander; Daphne Vassiliou; Rickard Wedin; Henrik Bauer; Göran Andersson
Journal:  Clin Exp Metastasis       Date:  2010-10-22       Impact factor: 5.150

9.  C-terminal modification of osteopontin inhibits interaction with the αVβ3-integrin.

Authors:  Brian Christensen; Eva Kläning; Mette S Nielsen; Mikkel H Andersen; Esben S Sørensen
Journal:  J Biol Chem       Date:  2011-12-16       Impact factor: 5.157

10.  Phosphorylation of osteopontin in osteoarthritis degenerative cartilage and its effect on matrix metalloprotease 13.

Authors:  Mai Xu; Lu Zhang; Lei Zhao; Shuguang Gao; Rui Han; Dazhi Su; Guanghua Lei
Journal:  Rheumatol Int       Date:  2012-11-07       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.